Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands

Annals of Oncology

Volumn 23, Issue 10, 2012, Pages 2743-2747

  Haasbeek, C J A ^a   Palma, D ^a,b   Visser, O ^c   Lagerwaard, F J ^a   Slotman, B ^a   Senan, S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c Integraal Kankercentrum Amsterdam   (Netherlands)

Author keywords

Elderly; Epidemiology; Lung cancer; SABR; SBRT; Stereotactic radiotherapy

Indexed keywords

AGED; ARTICLE; BILOBECTOMY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; DUTCH; EARLY CANCER; ETHNIC GROUP; GERIATRIC PATIENT; HEALTH CARE UTILIZATION; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SURGERY; MAJOR CLINICAL STUDY; NETHERLANDS; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; SLEEVE LOBECTOMY; STEREOTACTIC ABLATIVE RADIOTHERAPY; STEREOTACTIC TREATMENT; SUBLOBAR EXCISION; SURGICAL PATIENT; SURGICAL TECHNIQUE; SURVIVAL TIME; TREND STUDY;

EID: 84864336455     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds081     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12): 2893-2917.
2. Kris MG, Benowitz SI, Adams S et al. Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol 2010; 28(36): 5327-5347.
3. Detterbeck FC, Gibson CJ. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 2008; 3(7): 781-792.
4. Holmberg L, Sandin F, Bray F et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 2010; 65(5): 436-441.
5. Wouters MWJM, Siesling S, Jansen-Landheer ML et al. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol 2010; 36(Suppl 1): S83-S92.
6. Crino L, Weder W, van Meerbeeck J et al. Early stage and locally advanced (nonmetastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl 5): v103-v115.
7. Wisnivesky JP, Halm E, Bonomi M et al. Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer. Am J Respir Crit Care Med 2010; 181(3): 264-269.
8. Grutters JP, Kessels AG, Pijls-Johannesma M et al. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. Radiother Oncol 2010; 95(1): 32-40.
9. Potters L, Steinberg M, Rose C et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2004; 60(4): 1026-1032.
10. Uematsu M, Shioda A, Tahara K et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998; 82(6): 1062-1070.
11. Baumann P, Nyman J, Hoyer M et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009; 27(20): 3290-3296.
12. Timmerman R, Paulus R, Galvin J et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303(11): 1070-1076.
13. Haasbeek CJ, Lagerwaard FJ, Antonisse ME et al. Stage I nonsmall cell lung cancer in patients aged >/=75 years: outcomes after stereotactic radiotherapy. Cancer 2010; 116(2): 406-414.
14. NCI. Levels of Evidence for Adult and Pediatric Cancer Treatment Studies. NCI 2010; http://www.cancer.gov/cancertopics/pdq/levels-evidence-adult-treatment/ HealthProfessional/page2- (29 November 2011, date last accessed)
15. Palma D, Visser O, Lagerwaard FJ et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010; 28(35): 5153-5159.
16. Bentzen SM. Randomized controlled trials in health technology assessment: overkill or overdue? Radiother Oncol 2008; 86(2): 142-147.
17. Lagerwaard FJ, Haasbeek CJ, Smit EF et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008; 70(3): 685-692.
18. Muss HB Cancer in the elderly: a societal perspective from the United States. Clin Oncol 2009; 21(2): 92-98.
19. Ettinger DS, Akerley W, Bepler G et al. Non-small cell lung cancer. J Natl Compr Canc Netw 2010; 8(7): 740-801.
20. Allen MS, Darling GE, Pechet TT et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006; 81(3): 1013-1019.
21. Finlayson E, Fan Z, Birkmeyer JD. Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg 2007; 205(6): 729-734.
22. Bollen EC, Belgers E, van Haren EH, Siebenga J Surgical treatment of lung cancer with complete. VATS lobectomy, new in the Netherlands. Ned Tijdschr Geneeskd 2008; 152(21): 1204-1209.
23. Viney RC, Boyer MJ, King MT et al. Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non-small-cell lung cancer. J Clin Oncol 2004; 22(12): 2357-2362.
24. van Klaveren RJ, Oudkerk M, Prokop M et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361(23): 2221-2229.
25. Das IJ, Cheng CW, Chopra KL et al. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems. J Natl Cancer Inst 2008; 100(5): 300-307.
26. Hurkmans CW, Cuijpers JP, Lagerwaard FJ et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 2009; 41-14.
27. Hurkmans CW, van Lieshout M, Schuring D et al. Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study). Int J Radiat Oncol Biol Phys 2011; 80(3): 918-927.
28. Harley DP, Krimsky WS, Sarkar S et al. Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery: an alternative strategy. Ann Thorac Surg 2010; 89(2): 368-373.
29. van Tinteren H, Hoekstra OS, Smit EF et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected nonsmall-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359 (9315): 1388-1393.
30. Herder GJ, Kramer H, Hoekstra OS et al. Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol 2006; 24(12): 1800-1806.
31. Belgers EH, Siebenga J, Bosch AM et al. Complete video-assisted thoracoscopic surgery lobectomy and its learning curve. A single center study introducing the technique in the Netherlands. Interact Cardiovasc Thorac Surg 2010; 10(2): 176-180.
32. Sher DJ, Wee JO, Punglia RS. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011; 81(5): 767-774.
33. Lanni TBJ, Grills IS, Kestin LL et al. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer. Am J Clin Oncol 2011; 34(5): 494-498.